Om Genda

Om Genda, MD. Dr. Ganda is a board-certified specialist in Internal Medicine, Endocrinology and Metabolism, and Clinical Nutrition, a Senior Physician in the Section on Adult Diabetes, director of lipid clinic at Joslin, and an Associate Clinical Professor of Medicine at Harvard Medical School. Dr. Ganda received his medical degree from the S. M. S. Medical College of the University of Rajasthan in Jaipur, India, and completed a rotating internship at the S. M. S. Hospital. He completed a residency in medicine at the All India Institute of Medical Science in New Delhi, and a residency in medicine at Tufts University School of Medicine. Dr. Ganda subsequently completed a clinical fellowship in Endocrinology and Metabolism at Tufts University and a research fellowship in medicine at Harvard Medical School.

Linden Hu

Linden Hu, MD. Dr.Linden Hu is Professor of Medicine at Tufts University School of Medicine and Vice Chairman for Faculty Development in the Dept. of Medicine at Tufts-New England Medical Center. The focus his research is on Lyme disease for which he is the principal investigator of many NIH projects and has served as a planning member for recent NIAID conferences on Lyme diagnositics.

Rebecca Miksad

Rebecca Miksad, MD, MPH. Dr. Miksad is a medical oncologist at Beth Israel Deaconess Medical Center who specializes in the multidisciplinary treatment of hepatocellular cancer (HCC). Her research focuses on expanding HCC treatment options and defining optimal treatment strategies for HCC through clinical trials and decision analysis. She is founding oncologist of the BIDMC weekly multidisciplinary Liver Tumor Conference and is the primary oncologist at BIDMC who care for patients with liver tumors requiring chemoembolization. She served as the only oncologist on the United Network for Organ Sharing HCC Consensus Conference Liver Directed Therapy Working Group, contributed to the NIH HCC State of the Science meeting, participates in the National Institutes of Health Hepatobiliary Task Force and is a member of the adjuvant chemotherapy working group for the upcoming State of the Art Consensus Conference on HCC and Liver Transplantation.

Hannah Lee

Hannah Lee, MD, is currently assistant professor of medicine at Tufts Medical Center, affiliated with Tufts University School of Medicine. She did her medical school at University of North Carolina at Chapel Hill, and did both my residency and GI/ Hepatology fellowship at Tufts Medical Center. She is board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. Her specialty is in both general hepatology and transplant hepatology, and she care for patients with end-stage liver disease and liver cancer. She has special interest in viral hepatitis, particularly hepatitis B, and is the director of the Asian Pacific Wellness Program here at Tufts Medical Center. She is currently involved in two grant projects. One involves studying best practices in HBV screening in the Boston area and improving screening rates in the greater Boston Asian community. Another project she involved in is CME educational development both locally and nationally with focus on intervention in addressing key practice and knowledge gaps in HBV screening, counseling, linkage to care and adherence to clinical guidelines.

Ruth He

Ruth He, MD, PhD; Dr.He received her MD from Hunan Medical University and her PhD from East Carolina University School of Medicine. She is currently a medical Oncologist of Division of Hematology/Oncology, Assistant Professor at Georgetown University School of Medicine, Washington DC.  Dr.He is also an active researcher specializes in GI malignancy particularly in HCC, she is a principal investigator of several research projects and clinical trials of NIH and American Cancer Society.

Katherine Martien

Katherine Martien, MD: Dr.Martien is Neurodevelopmental Peditrician of LADDERS Clinic, Assistant in Pediatrics Massachusetts General Hospital for Children and Instructor, Harvard Medical School. She is not only a expert clinician treating autism but also she does research in the use of EEG to look at sensory and cognitive processing in Autism and in interictal spikes and their role in altering cognitive processing in autism. This work is in at risk infants and in affected children.

Georgina Garcia

Georgina Garcia, MD: Dr. Garcia is a Child and Adolescent Psychiatrist working at Children's Hospital Boston. She completed her undergraduate at Dartmouth College and went on to the University Of Iowa College Of Medicine for her medical degree. Dr. Garcia completed her adult psychiatric training at Tufts New England Medical Center and her child and adolescent psychiatry fellowship at Children's Hospital Boston. Since completion of her training Dr. Garcia has worked at the Martha Eliot Health Center, Children's Hospital Primary Care Center, and in private practice. Currently, Dr. Garcia works full time on the Pediatric Consultation Service at Children's Hospital Boston. She works as a liaison to the Cystic Fibrosis Center at Children's Hospital. Her research interests include depression in the medically ill population, delirium, Vitamin D and its relationship to mental health, and improving the mental health care systems for patients with Cystic Fibrosis.

Daryl Lau

Daryl Lau, MD, M.Sc, MPH: Dr. Lau is an Associate Professor of Medicine at Harvard Medical School (HMS) and serves as the Director of Translational Liver Research at Beth Israel Deaconess medical Center, HMS. Dr. Lau's major research interest has been the clinical and translational investigation of liver disease and in particularly viral hepatitis. She has conducted studies on the natural history and new therapeutic trials on hepatitis B, hepatitis C and delta hepatitis. She is the Program Director of the Harvard Hepatitis B Consortium, one of the clinical centers of the NIDDK-sponsored Hepatitis B Research Network. Her laboratory also serves as the Clinical Core for an NIAID sponsored Hepatitis C Center for the studies of innate immunity. Translational research projects in collaboration with basic scientists include the role of race and host genetic factors in determining interferon response in HCV infection using molecular, microarray techniques and microRNA technology.  Dr. Lau has been elected to “Best Doctors in America” in consecutive year since 2005. She serves as advisor and consultant for a number of national nonprofit organizations including Asian Health Foundation and Asian Pacific American Medical Students Association (APAMSA). She has numerous publications on viral hepatitis and liver diseases and serves in Editorial Board for a number of peer-review journals.